Guanfacine extended-release for attention-deficit/hyperactivity disorder (ADHD)

ISSN： 1465-6566

Source： Expert Opinion on Pharmacotherapy, Vol.11, Iss.15, 2010-10, pp. : 2549-2556

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Guanfacine Extended-Release: In Attention Deficit Hyperactivity Disorder

By Muir Victoria J. Perry Caroline M.

Drugs, Vol. 70, Iss. 13, 2010-09 ,pp. : 1693-1702

Adis International

Access to resources Recommend Favorite

Clonidine Extended-Release: In Attention-Deficit Hyperactivity Disorder

By Croxtall Jamie D.

Pediatric Drugs, Vol. 13, Iss. 5, 2011-10 ,pp. : 329-336

Adis International

Access to resources Recommend Favorite

Clonidine Extended-Release In Attention-Deficit Hyperactivity Disorder†: Profile Report

By Croxtall Jamie D.

CNS Drugs, Vol. 26, Iss. 3, 2012-03 ,pp. : 277-279

Adis International

Access to resources Recommend Favorite

Guanfacine ER for the treatment of adolescent attention-deficit/hyperactivity disorder

By Bukstein Oscar Gary Head Jared

Expert Opinion on Pharmacotherapy, Vol. 13, Iss. 15, 2012-10 ,pp. : 2207-2213

Informa Healthcare

Access to resources Recommend Favorite

Dexmethylphenidate Extended Release: In Attention-Deficit Hyperactivity Disorder

By Robinson Dean M. Keating Gillian M.

Drugs, Vol. 66, Iss. 5, 2006-01 ,pp. : 661-668

Adis International

Access to resources Recommend Favorite